175 related articles for article (PubMed ID: 34206699)
1. Benefits in the Macrophage Response Due to Graphene Oxide Reduction by Thermal Treatment.
Cicuéndez M; Casarrubios L; Barroca N; Silva D; Feito MJ; Diez-Orejas R; Marques PAAP; Portolés MT
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206699
[TBL] [Abstract][Full Text] [Related]
2. Macrophage inflammatory and metabolic responses to graphene-based nanomaterials differing in size and functionalization.
Cicuéndez M; Fernandes M; Ayán-Varela M; Oliveira H; Feito MJ; Diez-Orejas R; Paredes JI; Villar-Rodil S; Vila M; Portolés MT; Duarte IF
Colloids Surf B Biointerfaces; 2020 Feb; 186():110709. PubMed ID: 31841776
[TBL] [Abstract][Full Text] [Related]
3. Effects of Graphene Oxide and Reduced Graphene Oxide Nanostructures on CD4
Feito MJ; Cicuéndez M; Casarrubios L; Diez-Orejas R; Fateixa S; Silva D; Barroca N; Marques PAAP; Portolés MT
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142540
[TBL] [Abstract][Full Text] [Related]
4. Response of macrophages and neural cells in contact with reduced graphene oxide microfibers.
Serrano MC; Feito MJ; González-Mayorga A; Diez-Orejas R; Matesanz MC; Portolés MT
Biomater Sci; 2018 Nov; 6(11):2987-2997. PubMed ID: 30255874
[TBL] [Abstract][Full Text] [Related]
5. Internalization and cytotoxicity of graphene oxide and carboxyl graphene nanoplatelets in the human hepatocellular carcinoma cell line Hep G2.
Lammel T; Boisseaux P; Fernández-Cruz ML; Navas JM
Part Fibre Toxicol; 2013 Jul; 10():27. PubMed ID: 23849434
[TBL] [Abstract][Full Text] [Related]
6. The Molecular Influence of Graphene and Graphene Oxide on the Immune System Under In Vitro and In Vivo Conditions.
Dudek I; Skoda M; Jarosz A; Szukiewicz D
Arch Immunol Ther Exp (Warsz); 2016 Jun; 64(3):195-215. PubMed ID: 26502273
[TBL] [Abstract][Full Text] [Related]
7. A systems toxicology approach to the surface functionality control of graphene-cell interactions.
Chatterjee N; Eom HJ; Choi J
Biomaterials; 2014 Jan; 35(4):1109-27. PubMed ID: 24211078
[TBL] [Abstract][Full Text] [Related]
8. Characterization of M1 and M2 polarization phenotypes in peritoneal macrophages after treatment with graphene oxide nanosheets.
Feito MJ; Diez-Orejas R; Cicuéndez M; Casarrubios L; Rojo JM; Portolés MT
Colloids Surf B Biointerfaces; 2019 Apr; 176():96-105. PubMed ID: 30594708
[TBL] [Abstract][Full Text] [Related]
9. Effects of graphene oxide and reduced graphene oxide nanomaterials on porcine endothelial progenitor cells.
Polo-Montalvo A; Cicuéndez M; Casarrubios L; Barroca N; da Silva D; Feito MJ; Diez-Orejas R; Serrano MC; Marques PAAP; Portolés MT
Nanoscale; 2023 Nov; 15(42):17173-17183. PubMed ID: 37853851
[TBL] [Abstract][Full Text] [Related]
10. Cytokine Profiling of Primary Human Macrophages Exposed to Endotoxin-Free Graphene Oxide: Size-Independent NLRP3 Inflammasome Activation.
Mukherjee SP; Kostarelos K; Fadeel B
Adv Healthc Mater; 2018 Feb; 7(4):. PubMed ID: 29266859
[TBL] [Abstract][Full Text] [Related]
11. Investigating oxidation state-induced toxicity of PEGylated graphene oxide in ocular tissue using gene expression profiles.
Wu W; Yan L; Chen S; Li Q; Gu Z; Xu H; Yin ZQ
Nanotoxicology; 2018 Oct; 12(8):819-835. PubMed ID: 29888639
[TBL] [Abstract][Full Text] [Related]
12. Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung.
Duch MC; Budinger GR; Liang YT; Soberanes S; Urich D; Chiarella SE; Campochiaro LA; Gonzalez A; Chandel NS; Hersam MC; Mutlu GM
Nano Lett; 2011 Dec; 11(12):5201-7. PubMed ID: 22023654
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antibacterial activity through the controlled alignment of graphene oxide nanosheets.
Lu X; Feng X; Werber JR; Chu C; Zucker I; Kim JH; Osuji CO; Elimelech M
Proc Natl Acad Sci U S A; 2017 Nov; 114(46):E9793-E9801. PubMed ID: 29078354
[TBL] [Abstract][Full Text] [Related]
14. Dual Roles of Graphene Oxide To Attenuate Inflammation and Elicit Timely Polarization of Macrophage Phenotypes for Cardiac Repair.
Han J; Kim YS; Lim MY; Kim HY; Kong S; Kang M; Choo YW; Jun JH; Ryu S; Jeong HY; Park J; Jeong GJ; Lee JC; Eom GH; Ahn Y; Kim BS
ACS Nano; 2018 Feb; 12(2):1959-1977. PubMed ID: 29397689
[TBL] [Abstract][Full Text] [Related]
15. How macrophages respond to two-dimensional materials: a critical overview focusing on toxicity.
Lin H; Song Z; Bianco A
J Environ Sci Health B; 2021; 56(4):333-356. PubMed ID: 33760696
[TBL] [Abstract][Full Text] [Related]
16. Nano-biointeractions of PEGylated and bare reduced graphene oxide on lung alveolar epithelial cells: A comparative in vitro study.
Reshma SC; Syama S; Mohanan PV
Colloids Surf B Biointerfaces; 2016 Apr; 140():104-116. PubMed ID: 26741270
[TBL] [Abstract][Full Text] [Related]
17. An environment-friendly preparation of reduced graphene oxide nanosheets via amino acid.
Chen D; Li L; Guo L
Nanotechnology; 2011 Aug; 22(32):325601. PubMed ID: 21757797
[TBL] [Abstract][Full Text] [Related]
18. Graphene oxide and reduced graphene oxide-based scaffolds in regenerative medicine.
Raslan A; Saenz Del Burgo L; Ciriza J; Pedraz JL
Int J Pharm; 2020 Apr; 580():119226. PubMed ID: 32179151
[TBL] [Abstract][Full Text] [Related]
19. The rational designed graphene oxide-Fe
Yan D; Zhao H; Pei J; Wu X; Liu Y
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():659-666. PubMed ID: 28024635
[TBL] [Abstract][Full Text] [Related]
20. The role of the lateral dimension of graphene oxide in the regulation of cellular responses.
Yue H; Wei W; Yue Z; Wang B; Luo N; Gao Y; Ma D; Ma G; Su Z
Biomaterials; 2012 Jun; 33(16):4013-21. PubMed ID: 22381473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
